As stated the very significant cash positive $24M in the bank includes the marketing and production of their new "SUPREME" A2 Beta Casein protein Infant formula ready for sale.Equity-linked strategic alliance with lead Corporate Daigou distributor, Willis Trading
In March Bubs entered into a strategic equity-linked alliance with Willis Trading; Bubs’ single largest customer in FY21 and FY22, and the lead distributor for both Bubs® and CapriLac® brands in the Corporate Daigou Channel.
The agreement with Willis Trading is conditional on product purchase milestones of at least $50M in FY22 and $80M to $120M in FY23.
We have worked closely with Willis Trading for many years and together we have successfully returned Bubs® Daigou sales to record highs year to date, now exceeding pre-COVID levels. Strengthening our partnership with the Daigou community will align Bubs® brand power with deep channel engagement to provide additional visibility and reliability as we work together to rapidly accelerate our Chinese consumer base.
The company has enough cash to fund 4 quarters & is making stronger strategic decisions to grow the company even more around the globe in these troubled times
Equity-linked strategic alliance with lead Corporate Daigou...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $142.9M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.0¢ | 15.5¢ | $159.1K | 1.004M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 721892 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 1185728 | 22 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| BUB (ASX) Chart |